CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance the delivery of biological drugs using microvesicles, natural carriers that transport proteins and nucleic acids. It explores both synthetic and biological approaches to develop effective drug delivery systems targeting specific cells.
Current state-of-the-art drug carrier systems deliver new ‘biological drugs’ (like proteins and nucleic acids) poorly to the target site.
This is something I daily experience in my research on delivery of small interfering RNA.
The in vivo challenges are threefold:• Biological drugs are fragile molecules (subject to degradation and denaturation)• They need to gain access to the target site• They need delivery to a specific cell type and even to a specific subcellular location to be active.Recent…
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Utrecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
